TREATMENT FOR THE CHRONIC HEPATITIS B AMONG CHILDREN
Abstract
The article demonstrates the results of the clinical efficiency and tolerance of different antiviral therapy schemes (interferon, lamivudin and their combination) among children with chronic hepatitis b. the comparative research involved 85 children, who underwent the examination of the biochemical blood analysis, hepatitis b markers (Elisa, PCR), histological study of the liver tissues.
Key words: children, chronic hepatitis b, interferon, lamivudin.
About the Authors
T.V. Strokova
Scientific Center of Children Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
O.S. Gundobina
Scientific Center of Children Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
A.B. Galich
Scientific Center of Children Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
T.B. Sentsova
Scientific Center of Children Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
E.L. Tumanova
Scientific Center of Children Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
V.M. Senyakovich
Scientific Center of Children Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
A.S. Potapov
Scientific Center of Children Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
B.S. Kaganov
Research Institute of Nutrition, Russian Academy of Medical Sciences, Moscow
Russian Federation
For citations:
Strokova T.,
Gundobina O.,
Galich A.,
Sentsova T.,
Tumanova E.,
Senyakovich V.,
Potapov A.,
Kaganov B.
TREATMENT FOR THE CHRONIC HEPATITIS B AMONG CHILDREN. Pediatric pharmacology. 2007;4(3):6-12.
Views:
1822